EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics

Janina Marissen iD, Lilith Reichert, Christoph Härtel, Mats Ingmar Fortmann iD, Kirstin Faust, Delfina Msanga iD, Jürgen Harder, Michael Zemlin iD, Mercedes Gomez de Agüero iD, Katja Masjosthusmann, Alexander Humberg

International Journal of Molecular Sciences · 18.06.2024 · 25 (12) · 6684

DOI: 10.3390/ijms25126684 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2024. Verfasst von Janina Marissen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Würzburg, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: Infant, Premature, Microbiota, Antimicrobial Peptides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Else Kröner-Fresenius Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) are crucial components of the innate immune system in various organisms, including humans. Beyond their direct antimicrobial effects, AMPs play essential roles in various physiological processes. They induce angiogenesis, promote wound healing, modulate immune responses, and serve as chemoattractants for immune cells. AMPs regulate the microbiome and combat microbial infections on the skin, lungs, and gastrointestinal tract. Produced in response to microbial signals, AMPs help maintain a balanced microbial community and provide a first line of defense against infection. In preterm infants, alterations in microbiome composition have been linked to various health outcomes, including sepsis, necrotizing enterocolitis, atopic dermatitis, and respiratory infections. Dysbiosis, or an imbalance in the microbiome, can alter AMP profiles and potentially lead to inflammation-mediated diseases such as chronic lung disease and obesity. In the following review, we summarize what is known about the vital role of AMPs as multifunctional peptides in protecting newborn infants against infections and modulating the microbiome and immune response. Understanding their roles in preterm infants and high-risk populations offers the potential for innovative approaches to disease prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, PrematureMicrobiotaAntimicrobial PeptidesHumansInfant, NewbornImmunity, InnateAnimalsDysbiosis

Stichwörter der Autor:innen

antimicrobial peptidesdysbiosisepidermisinnate immune systemmicrobiomemicrobiota-regulation peptides/proteinspremature infantssustained inflammation

Substanzen

Antimicrobial Peptides

Autor:innen und Institutionen

  • Department of Pediatrics, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Würzburg Institute of Systems Immunology, Max-Planck Research Group, University of Würzburg, 97078 Würzburg, Germany.
  • German Center for Infection Research, Site Hamburg-Lübeck-Borstel-Riems, 23538 Lübeck, Germany.
  • Department of Pediatrics, University Hospital Schleswig-Holstein, 23538 Lübeck, Germany.
  • Department of Pediatrics, Bugando Hospital, Catholic University of Health and Allied Sciences, Mwanza 33109, Tanzania.
  • Department of Dermatology, Venerology and Allergology, Quincke Research Center, Kiel University, 24105 Kiel, Germany.

ORCID-Profile: Janina Marissen, Mats Ingmar Fortmann, Delfina Msanga, Michael Zemlin, Mercedes Gomez de Agüero

Förderung

  • Else Kröner-Fresenius-Stiftung
  • Else Kröner-Fresenius Stiftung

Zitieren

APA

Marissen, J., Reichert, L., Härtel, C., Fortmann, M. I., Faust, K., Msanga, D., Harder, J., Zemlin, M., Gomez de Agüero, M., Masjosthusmann, K., & Humberg, A. (2024). Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics. International Journal of Molecular Sciences, 25(12), 6684. https://doi.org/10.3390/ijms25126684

Vancouver

Marissen J, Reichert L, Härtel C, Fortmann MI, Faust K, Msanga D, et al. Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics. International Journal of Molecular Sciences. 2024;25(12):6684. doi:10.3390/ijms25126684

BibTeX
@article{Marissen2024,
  author = {Marissen, Janina and Reichert, Lilith and Härtel, Christoph and Fortmann, Mats Ingmar and Faust, Kirstin and Msanga, Delfina and Harder, Jürgen and Zemlin, Michael and Gomez de Agüero, Mercedes and Masjosthusmann, Katja and Humberg, Alexander},
  title = {Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6684},
  doi = {10.3390/ijms25126684}
}
Kostenlos starten →